Insight partner Mark Tunkel and co-founder Craig Scherer reveal foundation of development success in ONdrugDelivery Magazine lead story!
While combination product speed to market is no doubt top-of-mind for biologics manufacturers, today’s pharmaceutical marketplace dynamic begs for a more strategic approach to innovation based on the sheer number of available options for pharma industry developers to choose from.
Being the first to hit the ground running in delivery device development doesn’t ensure success, and making development decisions based on timeline alone may get a product to market faster – but deliver a sub-par user experience with low adoption. At the same time, layering in too much technology and complexity to compete with competitor product features alone may actually make it more difficult for users to stay on regimen.
Companies that make patient needs characterization the launching point for the development efforts will quickly discover this approach can be vital to navigating these development decisions successfully and driving patient adoption and health care provider prescription rates.
Read the full article here, on page 6: or – using the form below – contact us directly to learn how we can help with your product development pursuits.